AR034046A1 - Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la prostata - Google Patents

Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la prostata

Info

Publication number
AR034046A1
AR034046A1 ARP020101934A ARP020101934A AR034046A1 AR 034046 A1 AR034046 A1 AR 034046A1 AR P020101934 A ARP020101934 A AR P020101934A AR P020101934 A ARP020101934 A AR P020101934A AR 034046 A1 AR034046 A1 AR 034046A1
Authority
AR
Argentina
Prior art keywords
diseases
prostate
compositions
antiprogestines
treatment
Prior art date
Application number
ARP020101934A
Other languages
English (en)
Inventor
Jens Hoffmann
Rosemarie Lichtner
Gerd Siemeister
Ulrike Fuhrmann
Martin Schneider
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR034046A1 publication Critical patent/AR034046A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Métodos y usos para tratar enfermedades de la próstata, en particular cáncer de próstata e hiperplasia benigna de la próstata, en mamíferos macho, como antiprogestinas, en particular, la antiprogestina 11beta-(4-acetilfenil)-17beta-hidroxi-17alfa-(1,1,2,2,2-pentafluorofenil)-estra-4,9-dien-3-ona, o un derivado o análogo de la misma aceptable para uso farmacéutico. Composiciones farmacéuticas que comprenden dicha antiprogestina.
ARP020101934A 2001-05-25 2002-05-24 Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la prostata AR034046A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01250185 2001-05-25

Publications (1)

Publication Number Publication Date
AR034046A1 true AR034046A1 (es) 2004-01-21

Family

ID=8181589

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101934A AR034046A1 (es) 2001-05-25 2002-05-24 Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la prostata

Country Status (6)

Country Link
EP (1) EP1392399A1 (es)
JP (2) JP2004531561A (es)
AR (1) AR034046A1 (es)
PE (1) PE20021138A1 (es)
UY (1) UY27301A1 (es)
WO (1) WO2002094379A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE4039561A1 (de) * 1990-12-07 1992-07-09 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
DE4318371A1 (de) * 1993-05-28 1994-12-01 Schering Ag Mittel, enthaltend eine Verbindung mit antiandrogener sowie eine Verbindung mit kompetitiver, progesteronantagonistischer Wirkung
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE60121980T2 (de) * 2000-10-18 2007-03-01 Schering Ag Verwendung von 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-on zur herstellung eines medikaments zur behandlung von brust-, eierstock-, endometrium-krebs, myelom und meningiom
EP1328276B1 (en) * 2000-10-18 2005-11-23 Schering Aktiengesellschaft Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases

Also Published As

Publication number Publication date
UY27301A1 (es) 2003-02-28
WO2002094379A1 (en) 2002-11-28
JP2010077157A (ja) 2010-04-08
PE20021138A1 (es) 2003-01-11
EP1392399A1 (en) 2004-03-03
JP2004531561A (ja) 2004-10-14

Similar Documents

Publication Publication Date Title
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
ES2133270T3 (es) Terapia de combinacion para la profilaxis y/o el tratamiento de hiperplasia prostatica benigna.
BR0210056A (pt) composições e métodos para tratamento de hiperplasia
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
ATE556706T1 (de) Fettalkohol-arzneimittel-konjugate
CU23213A3 (es) Difenilureas sustituidas con omega-carboxiarilo como inhibidores de raf quinasa
UY26929A1 (es) Polipéptidos antiangiogénicos y métodos para inhibir la angiogénesis
BRPI0406796A (pt) Métodos para tratar hipertrofia prostática benigna, para reduzir um sintoma associado com a mesma, para reduzir o tamanho da próstata em um indivìduo humano e para profilaxia de bhp, composição farmacêutica oral de dose unitária, e, uso de lonidamina ou um análogo de lonidamina
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
CY1104981T1 (el) Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων
ES2157601T3 (es) Uso de agentes anti-microtubulos para tratar o prevenir la esclerosis multiple.
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
PA8481501A1 (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HUP0100586A2 (hu) Alsó húgyvezetéki tünetek kezelésére alkalmas gyógyászati készítmények
PT1420801E (pt) Utilização de fucanos no tratamento de adesões, artrite e psoríase
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
AR012626A1 (es) Una composicion farmaeutica que comprende un derivado o análogo de leptina como inhibidor de la proliferacion de células de tumor y el uso de dicha composicion farmaceutica para la manufactura de medicamento para el tratamiento de tumores
BR0111630A (pt) Espiral para inseto
BR0108728A (pt) Combinação farmacêutica terapêutica, e, método para tratar um c ncer.
PT912185E (pt) Novas formulacoes farmaceuticas contendo derivados de ester nitrato de esteroides proveitosos como farmacos anti-inflamatorios
ATE327973T1 (de) Polyamin-analoge als cytotoxische wirkstoffe
AR034046A1 (es) Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la prostata
AR029451A1 (es) Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia
ES2163634T3 (es) Benzopiranos y composiciones farmaceuticas que les contienen.
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser

Legal Events

Date Code Title Description
FA Abandonment or withdrawal